-
EP4182024
European procedure
- EP About this file
- EP Legal status
- EP Federated register
- EP Event history
- EP Citations
- EP Patent family
- EP All documents
Extract from the Register of European Patents
EP Citations: EP4182024
| Cited in | International search | Type: | Patent literature | Publication No.: | US2017231923
[Y] (GUY GEOFFREY [GB], et al) [Y] 1-14 * paragraphs [0002] , [0 99] * * claims 1-22 *; | Type: | Patent literature | Publication No.: | WO2019207319
[Y] (GW RES LTD [GB]) [Y] 1-14 * claims 1-43 *; | Type: | Patent literature | Publication No.: | WO2021055499
[XPYI] (ZYNERBA PHARMACEUTICALS INC [US]) [XP] 14 * claims 1-17 * * example 2; tables 2, 5 * [Y] 1-14[I] 1-14; | Type: | Non-patent literature | Publication information: | [XYI] - KUCHENBUCH MATHIEU ET AL, "Add-on cannabidiol significantly decreases seizures in 3 patients with SYNGAP1 developmental and epileptic encephalopathy", EPILEPSIA OPEN, vol. 5, no. 3, doi:10.1002/epi4.12411, ISSN 2470-9239, (20200604), pages 496 - 500, URL: https://onlinelibrary.wiley.com/doi/full-xml/10.1002/epi4.12411, XP055847803 [X] 14 * abstract * * figure 1; table 1 * * 4. Discussion * [Y] 1-14 [I] 1-14 | DOI: | http://dx.doi.org/10.1002/epi4.12411 | Type: | Non-patent literature | Publication information: | [XYI] - VLASKAMP DANIQUE R.M. ET AL, "SYNGAP1 encephalopathy. A distinctive generalized developmental and epileptic encephalopathy", NEUROLOGY, US, vol. 92, no. 2, doi:10.1212/WNL.0000000000006729, ISSN 0028-3878, (20190108), pages e96 - e107, URL: https://n.neurology.org/content/neurology/92/2/e96.full.pdf, XP055808006 [X] 14 * page e102, section "Epilepsy treatment and outcome";; figure 5 * [Y] 1-14 [I] 1-14 | DOI: | http://dx.doi.org/10.1212/WNL.0000000000006729 | Cited in | by applicant | Type: | Non-patent literature | Publication information: | - ROGER PERTWEE, Handbook of Cannabis, pages 3 - 15 |